https://doi.org/10.4081/btvb.2022.31
Is transient ischemic attack a minor stroke?
Submitted: 31 March 2022
Accepted: 30 April 2022
Published: 12 May 2022
Accepted: 30 April 2022
Abstract Views: 373
PDF: 200
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
In the current literature, the utility of transient ischemic attack (TIA) diagnosis is under revision by the scientific community and experts. If initially this term was considered a valid diagnostic category, over the years the definition of TIA has been completely subverted, underlining the scientific lability of this nosological entity [...]
Easton JD, Johnston SC. Time to retire the concept of transient ischemic attack. JAMA 2022;327:813.
DOI: https://doi.org/10.1001/jama.2022.0300
A classification and outline of cerebrovascular diseases II. Stroke 1975;6:564-616.
DOI: https://doi.org/10.1161/01.STR.6.5.564
Lioutas VA, Ivan CS, Himali JJ, et al. Incidence of transient ischemic attack and association with long-term risk of stroke. JAMA 2021;325:373.
DOI: https://doi.org/10.1001/jama.2020.25071
Giles MF, Rothwell PM. Systematic review and pooled analysis of published and unpublished validations of the
ABCD and ABCD2 transient ischemic attack risk scores. Stroke 2010;41:667-73.
DOI: https://doi.org/10.1161/STROKEAHA.109.571174
Weimar C, Benemann J, Michalski D, et al. Prediction of recurrent stroke and vascular death in patients with transient ischemic attack or nondisabling stroke. Stroke 2010;41:487-93.
DOI: https://doi.org/10.1161/STROKEAHA.109.562157
Song B, Fang H, Zhao L, et al. Validation of the ABCD 3 -I score to predict stroke risk after transient ischemic attack. Stroke 2013;44:1244-8.
DOI: https://doi.org/10.1161/STROKEAHA.113.000969
Brazzelli M, Chappell FM, Miranda H, et al. Diffusionweighted imaging and diagnosis of transient ischemic attack. Ann Neurol 2014;75:67-76.
DOI: https://doi.org/10.1002/ana.24026
Yu AYX, Coutts SB. Role of brain and vessel imaging for the evaluation of transient ischemic attack and minor stroke. Stroke 2018;49:1791-5.
DOI: https://doi.org/10.1161/STROKEAHA.118.016618
Mendelson SJ, Prabhakaran S. Diagnosis and management of transient ischemic attack and acute ischemic stroke. JAMA 2021;325:1088.
DOI: https://doi.org/10.1001/jama.2020.26867
Wang Y, Pan Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) trial. Circulation 2015;132:40-6.
DOI: https://doi.org/10.1161/CIRCULATIONAHA.114.014791
Pan Y, Elm JJ, Li H, et al. Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack. JAMA Neurol 2019;76:1466.
DOI: https://doi.org/10.1001/jamaneurol.2019.2531
How to Cite
Dolcetti, E. ., Bruno, A., & Centonze, D. (2022). Is transient ischemic attack a minor stroke?. Bleeding, Thrombosis and Vascular Biology, 1(1). https://doi.org/10.4081/btvb.2022.31
Copyright (c) 2022 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Most read articles by the same author(s)
- Federica Azzolini, Antonio Bruno, Ettore Dolcetti, Diego Centonze, Fabio Buttari, Tumor necrosis factor superfamily in multiple sclerosis: from pathology to therapeutic implications , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 2 (2023)
Similar Articles
- Setor K. Kunutsor, Sudhir Kurl, Ari Voutilainen, Jari Laukkanen, Circulating albumin-to-fibrinogen ratio may be a risk indicator for venous thromboembolism: findings from a population-based prospective cohort study , Bleeding, Thrombosis and Vascular Biology: Vol. 1 No. 2 (2022)
- Mosaad Almegren, Clinical and radiological characteristics of cerebral vein thrombosis: a retrospective study , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 3 (2023)
- Domenico Prisco, Irene Mattioli, Raffaele De Caterina, Alessandra Bettiol, The new era of anticoagulation: factor XI and XII inhibitors , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 2 (2023)
- Rossella Marcucci, Rosanna Abbate, What is the gender of thrombosis? A natural model of precision medicine , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 3 (2023)
- Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli, Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results , Bleeding, Thrombosis and Vascular Biology: Vol. 1 No. 1 (2022)
- Giovanni de Gaetano, Chiara Cerletti, Licia Iacoviello, Maria Benedetta Donati, The night of randomized clinical trials where all patients are black: a need to estimate variability in treatment effects , Bleeding, Thrombosis and Vascular Biology: Vol. 1 No. 1 (2022)
- Kristen M. Sanfilippo, Tzu-Fei Wang, Venous thromboembolism and mortality in patients with hematological malignancies , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. s1 (2024): 12th ICTHIC
- Anna Falanga, Hugo Ten Cate, Bianca Rocca, How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 1 (2023)
- Anne Eichmann, The Lefoulon Delalande Foundation honors the lymphatic vascular system , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 4 (2023)
- Sergio Coccheri, A re-appraisal of thrombogenesis in COVID-19, seen as a multiple "Complex system" , Bleeding, Thrombosis and Vascular Biology: Vol. 1 No. 3 (2022)
You may also start an advanced similarity search for this article.
